Regulation News
Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.
SSE Executives Acquire Shares Ahead of Major Grid Investment Phase
SSE PLC disclosed that CEO Martin Pibworth and six other senior executives acquired shares through the company's all-employee plan ahead of a closed period. The move comes as SSE embarks on a £33 billion, five-year grid investment program.
LSEG Unveils Comprehensive ESG Scoring Ahead of EU Regulatory Deadline
London Stock Exchange Group has introduced a major ESG scoring and analytics platform, covering thousands of companies and bonds, as it prepares for upcoming European sustainability regulations. The launch follows a significant share repurchase program and ongoing investor pressure for growth.
Ford Issues Massive Recall for 1 Million Vehicles, Stock Dips
Ford Motor Company is initiating a recall covering approximately 1.02 million vehicles in the United States due to windshield wiper motor and rear suspension issues. The automaker's shares declined about 1% following the announcement.
Atara Biotherapeutics Surges on FDA Leadership Shift, EBVALLO Review in Focus
Atara Biotherapeutics shares surged 18% Monday following news of an upcoming FDA leadership change, reviving investor hope for a reconsideration of its rejected EBVALLO therapy for a rare blood cancer.
Reviva Pharma Enacts Reverse Split to Fend Off Nasdaq Delisting
Reviva Pharmaceuticals Holdings has implemented a 1-for-20 reverse stock split to boost its share price and avoid a Nasdaq delisting, with a critical compliance deadline of March 27. The company also faces financing challenges for an additional Phase 3 trial of its schizophrenia drug candidate, brilaroxazine.
uniQure Shares Soar on FDA Leadership Shift Amid Gene Therapy Dispute
uniQure shares jumped 34% in premarket trading following news that FDA biologics chief Vinay Prasad will depart in April. The move comes amid a regulatory standoff over the company's Huntington's disease gene therapy.
Palantir Faces Pentagon AI Ban Fallout as Defense Tech Reliance Questioned
Palantir Technologies confronts new risks as the U.S. Pentagon designates AI supplier Anthropic a supply-chain threat, raising concerns over its defense software dependencies. Broader market jitters add to the pressure.
Kenvue Grants Executive Stock Awards Amid $40B Kimberly-Clark Acquisition Wait
Kenvue has issued new restricted stock unit awards to top executives, including North America head Carlos De Jesus and General Counsel Matthew Orlando, while awaiting regulatory approval for its $40 billion acquisition by Kimberly-Clark.
FAA Tightens Chicago O'Hare Summer Flight Cap, Squeezing American Airlines' Expansion
The Federal Aviation Administration is pushing for a stricter daily flight limit at Chicago O'Hare this summer, potentially forcing deeper cuts than airlines anticipated. This creates a significant hurdle for American Airlines, which had planned a major expansion at the airport.
UK Regulator Backs SSE's Early Grid Investment in Scotland
Britain's energy regulator Ofgem has signaled support for SSE's request for early construction funding on eight major Scottish transmission projects, potentially allowing accelerated spending ahead of final approvals.
BAT Hit with UK Shareholder Suit Over North Korea Sanctions
British American Tobacco is being sued in London by over 100 shareholders who allege the company did not properly disclose U.S. sanctions violations related to its North Korea operations. The legal action follows BAT's $635.2 million settlement with U.S. authorities in 2023.
Malaysia Affirms Strict Lynas License Terms Despite US Minerals Pact
Malaysia's trade ministry clarified that a US critical minerals agreement does not override technical requirements for Lynas Rare Earths' operations, following the firm's 10-year license renewal. Environmental groups continue to oppose radioactive waste storage.